We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Young Innovations, Inc. (MM) | NASDAQ:YDNT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 39.48 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
NEW YORK, Dec. 17, 2012 /PRNewswire/ --
Intermec Inc.
Levi & Korsinsky is investigating the Board of Directors of Intermec Inc. (NYSE: IN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Honeywell International Inc. ("Honeywell") (NYSE: HON) for $10 per share.
Click here to learn more about the investigation: http://9nl.com/intermec/, or call: 877-363-5972.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )
Somaxon Pharmaceuticals, Inc.
Levi & Korsinsky is investigating the Board of Directors of Somaxon Pharmaceuticals, Inc. (NasdaqCM: SOMX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX).
Click here to learn more about the investigation: http://zlk.9nl.com/somaxon-pharmaceuticals-somx/, or call: 877-363-5972.
Clearwire Corp.
Levi & Korsinsky is investigating the Board of Directors of Clearwire Corp. (Nasdaq: CLWR) for possible breaches of fiduciary duty and other violations of state law in connection with the proposed sale of the Company to Sprint Nextel Corp. ("Sprint") (NYSE: S). Under the deal, Sprint has offered to buy the 49% of Clearwire stock it currently doesn't own for $2.907 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/clearwire-clwr/, or call: 877-363-5972.
Young Innovations, Inc.
Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (NasdaqGS: YDNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to an affiliate of Linden Capital Partners for $39.50 per share. Young Innovations stock traded above the offer price as recently as September 27, 2012.
Click here to learn more: http://zlk.9nl.com/young-innovations-ydnt.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
SOURCE Levi & Korsinsky, LLP
Copyright 2012 PR Newswire
1 Year Young Innovations, Inc. (MM) Chart |
1 Month Young Innovations, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
